Approach to BCRL screening

BRCL risk by surgery type	Preoperative baseline measurements	Patient education	Follow-up (years 1 to 3)	Follow-up (years 4 to 5)
High (eg, ALND)	Comparison with postoperative measurements increases accuracy of BRCL diagnosis	Individualized risk factors Screening program components Signs and symptoms of BRCL Signs and symptoms of infection/cellulitis When to contact treatment team Who to contact for signs/symptoms of BRCL of infection/cellulitis	Every 3 to 6 month	Every 6 months
Low (eg, SLNB)			Every 6 to 12 months or home self-monitoring

ANLD: axillary lymph node dissection; BRCL: breast cancer-related lymphedema; SLNB: sentinel lymph node biopsy.

References:

Boyages J, Vicini FA, Manavi BA, et al. Axillary treatment and chronic breast cancer-related lymphedema: Implications for prospective surveillance and intervention from a randomized controlled trial. JCO Oncol Pract 2023; 19:1116.
Bundred N, Foden P, Todd C, et al. Increases in arm volume predict lymphoedema and quality of life deficits after axillary surgery: A prospective cohort study. Br J Cancer 2020; 123:17.
McDuff SGR, Mina AI, Brunelle CL, et al. Timing of lymphedema after treatment for breast cancer: When are patients most at risk? Int J Radiat Oncol Biol Phys 2019; 103:62.

Graphic 145319 Version 1.0